New international reporting guidelines for clinical trials evaluating effectiveness of artificial intelligence interventions in dermatology: strengthening the SPIRIT of robust trial reporting
Open Access
- 5 March 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (3) , 381-383
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- What is AI? Applications of artificial intelligence to dermatologyBritish Journal of Dermatology, 2020
- Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditionsAnnals of Oncology, 2020
- Assessment of Accuracy of an Artificial Intelligence Algorithm to Detect Melanoma in Images of Skin LesionsJAMA Network Open, 2019
- A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysisThe Lancet Digital Health, 2019
- Skin cancer detection by deep learning and sound analysis algorithms: A prospective clinical study of an elementary dermoscopeEBioMedicine, 2019
- Dermoscopy diagnosis of cancerous lesions utilizing dual deep learning algorithms via visual and audio (sonification) outputs: Laboratory and prospective observational studiesEBioMedicine, 2019
- The quality of reporting randomized controlled trials in the dermatology literature in an era where the CONSORT statement is a standardBritish Journal of Dermatology, 2018
- SPIRIT 2013: new guidance for content of clinical trial protocolsThe Lancet, 2013
- CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trialsInternational Journal of Surgery, 2011
- Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trialMelanoma Research, 2009